Literature DB >> 3100662

Increased specificity of serodiagnosis of Chagas' disease by detection of antibody to the 72- and 90-kilodalton glycoproteins of Trypanosoma cruzi.

L V Kirchhoff, A A Gam, R A Gusmao, R S Goldsmith, J M Rezende, A Rassi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3100662     DOI： 10.1093/infdis/155.3.561

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  16 in total

1.  Serologic testing for Trypanosoma cruzi: comparison of radioimmunoprecipitation assay with commercially available indirect immunofluorescence assay, indirect hemagglutination assay, and enzyme-linked immunosorbent assay kits.

Authors:  D A Leiby; S Wendel; D T Takaoka; R M Fachini; L C Oliveira; M A Tibbals
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

2.  The emergence of chagas disease in the United States and Canada.

Authors:  Louis V Kirchhoff; Richard D Pearson
Journal:  Curr Infect Dis Rep       Date:  2007-09       Impact factor: 3.725

3.  Comparison of PCR and microscopic methods for detecting Trypanosoma cruzi.

Authors:  L V Kirchhoff; J R Votava; D E Ochs; D R Moser
Journal:  J Clin Microbiol       Date:  1996-05       Impact factor: 5.948

4.  Serological diagnosis of Chagas' disease: a potential confirmatory assay using preserved protein antigens of Trypanosoma cruzi.

Authors:  R P Mendes; S Hoshino-Shimizu; A M Moura da Silva; I Mota; R A Heredia; A O Luquetti; P G Leser
Journal:  J Clin Microbiol       Date:  1997-07       Impact factor: 5.948

5.  Use of full-length recombinant calflagin and its c fragment for improvement of diagnosis of Trypanosoma cruzi infection.

Authors:  Iván S Marcipar; Cintia Roodveldt; Gerardo Corradi; María L Cabeza; Maria Edileuza F Brito; Lucile M Floeter Winter; Alberto J Marcipar; Ariel M Silber
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

6.  Design, construction, and evaluation of a specific chimeric antigen to diagnose chagasic infection.

Authors:  Sebastián Aguirre; Ariel M Silber; Maria Edileuza F Brito; María E Ribone; Claudia M Lagier; Iván S Marcipar
Journal:  J Clin Microbiol       Date:  2006-10       Impact factor: 5.948

7.  Lateral flow immunoassay for diagnosis of Trypanosoma cruzi infection with high correlation to the radioimmunoprecipitation assay.

Authors:  Raymond L Houghton; Yvonne Y Stevens; Kathryn Hjerrild; Jeff Guderian; Masahiko Okamoto; Mazbahul Kabir; Steven G Reed; David A Leiby; W John W Morrow; Myriam Lorca; Syamal Raychaudhuri
Journal:  Clin Vaccine Immunol       Date:  2009-02-11

8.  Immunoblot assay using recombinant antigens as a supplemental test to confirm the presence of antibodies to Trypanosoma cruzi.

Authors:  Kevin Y Cheng; Chi-Deu Chang; Vince A Salbilla; Louis V Kirchhoff; David A Leiby; Gerald Schochetman; Dinesh O Shah
Journal:  Clin Vaccine Immunol       Date:  2007-02-07

9.  Antibody levels correlate with detection of Trypanosoma cruzi DNA by sensitive polymerase chain reaction assays in seropositive blood donors and possible resolution of infection over time.

Authors:  Ester C Sabino; Tzong-Hae Lee; Lani Montalvo; Megan L Nguyen; David A Leiby; Danielle M Carrick; Marcia M Otani; Elizabeth Vinelli; David Wright; Susan L Stramer; Michael Busch
Journal:  Transfusion       Date:  2012-09-25       Impact factor: 3.157

10.  Diagnosis of parasitic diseases: old and new approaches.

Authors:  Momar Ndao
Journal:  Interdiscip Perspect Infect Dis       Date:  2009-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.